Platform Optimizing SynBio for Early Intervention and Detection in Oncology: catching cancer early with simple tests.
POSEIDON is an ARPA-H program developing approaches to multi-cancer early detection. Its research aims to combine synthetic sensors and reporters with low-cost, self-administered screening kits that use breath or urine samples to detect 30 or more solid tumors at Stage I. The envisioned kits are designed for at-home use and would connect results with electronic health records and a health professional for review. ARPA-H describes work across sensor development and the hardware and software needed for a screening kit.
Be the first Cosign
Add it to your Products I use list. You can also share why you use it.
